Chondrial Therapeutics, Inc.

What looked like increasing momentum for Larimar Therapeutics, Inc. ’s program to develop the first drug therapy for Friedrich’s ataxia was dashed at least temporarily on 25 May, as the company annou

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Roche Pays Rheos $42.5m Up F

Abbisko Therapeutics Abbisko brings in $28mm via Series A China-based Abbisko Therapeutics raised $28mm through its Series A financing to Lilly Asia Ventures, Sinopharm Capital, Jianxin Capita

Below is Scrip’s monthly roundup, compiled by Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Boehringer And Vander